Arete Wealth Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$470K Buy
1,159
+154
+15% +$62.5K 0.03% 425
2025
Q1
$500K Buy
1,005
+126
+14% +$62.7K 0.04% 393
2024
Q4
$457K Buy
879
+536
+156% +$279K 0.03% 436
2024
Q3
$212K Sell
343
-395
-54% -$244K 0.02% 637
2024
Q2
$407K Buy
+738
New +$407K 0.03% 438
2024
Q1
Sell
-794
Closed -$422K 699
2023
Q4
$422K Buy
794
+175
+28% +$92.9K 0.03% 447
2023
Q3
$314K Buy
619
+33
+6% +$16.7K 0.05% 336
2023
Q2
$306K Sell
586
-514
-47% -$268K 0.03% 493
2023
Q1
$634K Sell
1,100
-46
-4% -$26.5K 0.05% 291
2022
Q4
$631M Sell
1,146
-44
-4% -$24.2M 0.06% 279
2022
Q3
$604K Sell
1,190
-9,901
-89% -$5.03M 0.06% 264
2022
Q2
$808K Buy
11,091
+10,087
+1,005% +$735K 0.08% 178
2022
Q1
$593K Sell
1,004
-125
-11% -$73.8K 0.05% 254
2021
Q4
$734K Buy
1,129
+291
+35% +$189K 0.06% 223
2021
Q3
$479K Buy
838
+41
+5% +$23.4K 0.05% 265
2021
Q2
$363K Sell
797
-45
-5% -$20.5K 0.05% 239
2021
Q1
$384K Sell
842
-3
-0.4% -$1.37K 0.05% 280
2020
Q4
$394K Sell
845
-2,593
-75% -$1.21M 0.06% 265
2020
Q3
$1.5M Buy
3,438
+134
+4% +$58.3K 0.23% 105
2020
Q2
$1.2M Sell
3,304
-272
-8% -$98.5K 0.21% 124
2020
Q1
$1.01M Sell
3,576
-3
-0.1% -$851 0.2% 115
2019
Q4
$1.16M Sell
3,579
-17
-0.5% -$5.52K 0.2% 117
2019
Q3
$1.05M Sell
3,596
-331
-8% -$96.4K 0.2% 124
2019
Q2
$1.15M Buy
3,927
+115
+3% +$33.8K 0.22% 111
2019
Q1
$1.04M Buy
3,812
+1,199
+46% +$328K 0.22% 120
2018
Q4
$585K Buy
2,613
+1,365
+109% +$306K 0.14% 173
2018
Q3
$305K Buy
+1,248
New +$305K 0.07% 265